Advances in Automatic Quantification of White Matter - - PowerPoint PPT Presentation

advances in automatic quantification
SMART_READER_LITE
LIVE PREVIEW

Advances in Automatic Quantification of White Matter - - PowerPoint PPT Presentation

Advances in Automatic Quantification of White Matter Hyperintensities November 2, 2017 Vivek Gupta, MD, Neuroradiologist, Mayo Clinic Matt Berseth, Lead Scientist, NLP LOGIX Topics White Matter Disease Clinical Importance of WMH


slide-1
SLIDE 1

Advances in Automatic Quantification

  • f White Matter Hyperintensities

November 2, 2017 Vivek Gupta, MD, Neuroradiologist, Mayo Clinic Matt Berseth, Lead Scientist, NLP LOGIX

slide-2
SLIDE 2

Topics

White Matter Disease Clinical Importance of WMH Quantification WMH Automated Algorithms MICCAI WMH Challenge

slide-3
SLIDE 3

White Matter Disease

White matter hyperintensities (WMH, also known as leukoaraiosis), are widely observed in the ageing population The abnormal signal, explained by a change in the fat/water ratio, reflects injury to the white matter Multiple sclerosis and other demyelinating diseases primarily affect white matter leading to characteristic WMH

Longitudinal segmentation of age-related white matter hyperintensities C.H. Sudreet al. / Medical Image Analysis 38 (2017) BohlegaS, Al ShubiliA, Edris A, AlreshaidA, AlkhairallahT, AlSousMW, Farah S, Abu-Amero KK. -CADASIL in Arabs: clinical and genetic findings. BMC Medical Genetics 2007, 8:67doi:10.1186/1471-2350-8-67, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=3441739

slide-4
SLIDE 4

Clinical Impact of WMH

WMHs are common in patients with cardiovascular risk factors such as hypertension, diabetes; and cerebrovascular disease WMH’s are associated with increased risk of functional decline, dementia, and death Quantitation and longitudinal monitoring of WMH is

  • f major importance in clinical medicine,

cerebrovascular research and drug trials in multiple sclerosis

2017 2016

slide-5
SLIDE 5

Quantifying WMH

Growing need for reliable quantification of WHM to better understand their diagnostic and prognostic value in both healthy and diseased populations Lesion size, location, total WMH burden and

  • verall white matter volume

Visual rating scales: Fazekas scale, Scheltensscale and the age-related white matter changes (ARWMC) scale

BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities

slide-6
SLIDE 6

Quantification Challenges

  • Visual scales are seldom comparable (Scheltenset al. 1998)
  • Lack critical clinically important information about spatial

distribution of WMH

  • Visual scales are not appropriate when examining

longitudinal progression of WMH (Prinset al. 2004)

  • Show poor sensitivity to clinical group differences (Mantyla

et al. 1997)

  • High intra-subject and inter-subject variability (van den

Heuvel et al. 2006) Manual quantification of WMH areas is more reliable, but the processing involved is far too cumbersome and time consuming for practical utility

Automatic Detection of White Matter Hyperintensities in HealthyAgingand Pathology Using Magnetic Resonance Imaging:AReview

slide-7
SLIDE 7

Quantification Challenges

Voxel-wise WMH maps can be used to quantitate and better understand relationship between WMH and specific symptoms Semi-automated voxel-based morphometry requires considerable manual processing and lack generalizability across different MRI hardware and scanning technique for widespread application Need – accurate, objective and automated method to quantitate and spatio-temporally map WMH with adaptive perpetual learning capability

references

slide-8
SLIDE 8

Algorithmic WMH Segmentation and Quantification

slide-9
SLIDE 9

Automated WMH Algorithms ‘in-house’ algorithms Study or protocol specific Small sample sizes Not evaluated on publicly available data set

references

slide-10
SLIDE 10

BIANCA

Automated Algorithm Multiple MRI protocols Key options

references

slide-11
SLIDE 11

BIANCA

Automated Algorithm Multiple MRI protocols Key options

references

Requires retraining By protocol Adapted to each dataset

slide-12
SLIDE 12

WMH Challenge

Aim: Directly compare methods for automatic segmentation of WMH Many published techniques Issues:

  • Different ground truth
  • Different evaluation metrics
  • Different data sets
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

WMH Challenge – Reference Standard

WMH manually segmented by Observer 1 (O1), then peer reviewed corrected by Observer 2 (O2) Binary masks created from annotations used as ground truth

Currently gathering Observer 3 (O3) segmentations, estimate is inter-observer Dice of 0.8

Image: https://ww5.aievolution.com/hbm1701/index.cfm?do=abs.viewAbs&abs=1574

slide-17
SLIDE 17
slide-18
SLIDE 18

Deep, Multi-scale, Convolutional Network

FC 400 FC 400 FC 200 WMH Positive WMH Negative

slide-19
SLIDE 19

WMH Model Highlights

Skull stripping using FSL 399,716 positive patches 550,000 negative patches Upsampled high-intensity negative FLAIR ReLU, Dropout in FC layers, Batch Norm No pooling, mini-batch size of 768

references

slide-20
SLIDE 20

references

slide-21
SLIDE 21

references

slide-22
SLIDE 22

Example Auto-Segmented Scans

references

slide-23
SLIDE 23

Key Metrics in Automated Quantification

  • Total WMH Volume
  • Total # of Lesions
  • Localization of Lesions
  • Registration of WMH to atlas

Longitudinal monitoring

  • Progression, Regression, Stability
  • New Lesions
  • Lesion Growth

references

slide-24
SLIDE 24

The Challenge of f Accurate Detection Initial One year later

slide-25
SLIDE 25

The Problem of f Quantification and Longitudinal Monitoring

Ten years ago Current

slide-26
SLIDE 26

What next:

  • Additional training data
  • Additional validation
  • Deploy for clinical use
slide-27
SLIDE 27

Thank you